• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

食管癌患者的代谢紊乱及潜在标志物

Metabolic Perturbation and Potential Markers in Patients with Esophageal Cancer.

作者信息

Zhu Xianlan, Wang Kun, Liu Gaoshuang, Wang Yuqing, Xu Jin, Liu Linsheng, Li Mengjie, Shi Jian, Aa Jiye, Yu Lianzhen

机构信息

Department of Gastroenterology, The First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing 210029, China.

Department of Gastroenterology, Wuxi People's Hospital Affiliated to Nanjing Medical University, 299 Qingyang Road, Wuxi 214023, China.

出版信息

Gastroenterol Res Pract. 2017;2017:5469597. doi: 10.1155/2017/5469597. Epub 2017 Apr 20.

DOI:10.1155/2017/5469597
PMID:28512469
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5415862/
Abstract

Clinical diagnosis of esophageal cancer (EC) at early stage is rather difficult. This study aimed to profile the molecules in serum and tissue and identify potential biomarkers in patients with EC. A total of 64 volunteers were recruited, and 83 samples (24 EC serum samples, 21 serum controls, 19 paired EC tissues, and corresponding tumor-adjacent tissues) were analyzed. The gas chromatography time-of-flight mass spectrometry (GC/TOF-MS) was employed, and principal component analysis was used to reveal the discriminatory metabolites and identify the candidate markers of EC. A total of 41 in serum and 36 identified compounds in tissues were relevant to the malignant prognosis. A marked metabolic reprogramming of EC was observed, including enhanced anaerobic glycolysis and glutaminolysis, inhibited tricarboxylic acid (TCA) cycle, and altered lipid metabolism and amino acid turnover. Based on the potential markers of glucose, glutamic acid, lactic acid, and cholesterol, the receiver operating characteristic (ROC) curves indicated good diagnosis and prognosis of EC. EC patients showed distinct reprogrammed metabolism involved in glycolysis, TCA cycle, glutaminolysis, and fatty acid metabolism. The pivotal molecules in the metabolic pathways were suggested as the potential markers to facilitate the early diagnosis of human EC.

摘要

早期食管癌(EC)的临床诊断相当困难。本研究旨在分析血清和组织中的分子,并鉴定食管癌患者的潜在生物标志物。共招募了64名志愿者,分析了83个样本(24份食管癌血清样本、21份血清对照、19对配对的食管癌组织及相应的癌旁组织)。采用气相色谱 - 飞行时间质谱(GC/TOF-MS),并通过主成分分析揭示具有鉴别作用的代谢物,确定食管癌的候选标志物。血清中共有41种、组织中共有36种已鉴定的化合物与恶性预后相关。观察到食管癌存在明显的代谢重编程,包括无氧糖酵解和谷氨酰胺分解增强、三羧酸(TCA)循环受抑制、脂质代谢和氨基酸周转改变。基于葡萄糖、谷氨酸、乳酸和胆固醇的潜在标志物,受试者工作特征(ROC)曲线表明对食管癌具有良好的诊断和预后价值。食管癌患者在糖酵解、TCA循环、谷氨酰胺分解和脂肪酸代谢中表现出明显的代谢重编程。代谢途径中的关键分子被认为是有助于人类食管癌早期诊断的潜在标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07bf/5415862/424a603d83b5/GRP2017-5469597.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07bf/5415862/f88a709a24c5/GRP2017-5469597.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07bf/5415862/11d18396b496/GRP2017-5469597.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07bf/5415862/98dc153a924a/GRP2017-5469597.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07bf/5415862/424a603d83b5/GRP2017-5469597.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07bf/5415862/f88a709a24c5/GRP2017-5469597.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07bf/5415862/11d18396b496/GRP2017-5469597.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07bf/5415862/98dc153a924a/GRP2017-5469597.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07bf/5415862/424a603d83b5/GRP2017-5469597.004.jpg

相似文献

1
Metabolic Perturbation and Potential Markers in Patients with Esophageal Cancer.食管癌患者的代谢紊乱及潜在标志物
Gastroenterol Res Pract. 2017;2017:5469597. doi: 10.1155/2017/5469597. Epub 2017 Apr 20.
2
H NMR-based metabolomics of paired esophageal tumor tissues and serum samples identifies specific serum biomarkers for esophageal cancer.基于 1H NMR 的配对食管肿瘤组织和血清样本代谢组学分析鉴定出食管癌的特异性血清生物标志物。
NMR Biomed. 2021 Jun;34(6):e4505. doi: 10.1002/nbm.4505. Epub 2021 Mar 30.
3
GC/TOFMS analysis of metabolites in serum and urine reveals metabolic perturbation of TCA cycle in db/db mice involved in diabetic nephropathy.GC/TOFMS 分析血清和尿液中的代谢物揭示了 db/db 小鼠糖尿病肾病中 TCA 循环代谢紊乱。
Am J Physiol Renal Physiol. 2013 Jun 1;304(11):F1317-24. doi: 10.1152/ajprenal.00536.2012. Epub 2013 Mar 6.
4
Metabolic signatures of esophageal cancer: NMR-based metabolomics and UHPLC-based focused metabolomics of blood serum.食管癌的代谢特征:基于核磁共振的血清代谢组学和基于超高效液相色谱的血清靶向代谢组学
Biochim Biophys Acta. 2013 Aug;1832(8):1207-16. doi: 10.1016/j.bbadis.2013.03.009. Epub 2013 Mar 20.
5
Nuclear magnetic resonance-based metabolomics and metabolic pathway networks from patient-matched esophageal carcinoma, adjacent noncancerous tissues and urine.基于核磁共振的代谢组学及代谢通路网络分析,研究对象为配对的食管癌、癌旁非肿瘤组织及尿液。
World J Gastroenterol. 2019 Jul 7;25(25):3218-3230. doi: 10.3748/wjg.v25.i25.3218.
6
Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.使用支气管肺泡灌洗液和集成直接进样/气相色谱质谱平台对潜在肺癌生物标志物进行代谢谱分析。
J Proteomics. 2016 Aug 11;145:197-206. doi: 10.1016/j.jprot.2016.05.030. Epub 2016 May 30.
7
Study of the metabolomics characteristics of patients with metabolic syndrome based on liquid chromatography quadrupole time-of-flight mass spectrometry.基于液相色谱-四极杆飞行时间质谱的代谢综合征患者代谢组学特征研究。
Ann Endocrinol (Paris). 2018 Feb;79(1):37-44. doi: 10.1016/j.ando.2017.05.005. Epub 2017 Dec 13.
8
Metabolic shifts induced by human H460 cells in tumor-bearing mice.
Biomed Chromatogr. 2016 Mar;30(3):337-42. doi: 10.1002/bmc.3553. Epub 2015 Aug 17.
9
Serum Metabolomic Profiling to Reveal Potential Biomarkers for the Diagnosis of Fatty Liver Hemorrhagic Syndrome in Laying Hens.血清代谢组学分析以揭示蛋鸡脂肪肝出血综合征诊断的潜在生物标志物
Front Physiol. 2021 Feb 9;12:590638. doi: 10.3389/fphys.2021.590638. eCollection 2021.
10
Analysis of urinary metabolic signatures of early hepatocellular carcinoma recurrence after surgical removal using gas chromatography-mass spectrometry.采用气相色谱-质谱联用技术分析手术切除后早期肝细胞癌复发的尿代谢特征。
J Proteome Res. 2012 Aug 3;11(8):4361-72. doi: 10.1021/pr300502v. Epub 2012 Jul 24.

引用本文的文献

1
Challenges in the diagnosis of esophageal cancer with intramural gastric metastasis: Two case reports.伴有壁内胃转移的食管癌诊断挑战:两例报告
World J Gastrointest Oncol. 2025 Aug 15;17(8):110206. doi: 10.4251/wjgo.v17.i8.110206.
2
Causal association of metabolic biomarkers and the risk of esophageal cancer: A 2-sample Mendelian randomization study.代谢生物标志物与食管癌风险的因果关联:一项两样本孟德尔随机化研究。
Medicine (Baltimore). 2025 Aug 1;104(31):e43295. doi: 10.1097/MD.0000000000043295.
3
Nanomedicines Targeting Metabolic Pathways in the Tumor Microenvironment: Future Perspectives and the Role of AI.

本文引用的文献

1
HSulf-1 deficiency dictates a metabolic reprograming of glycolysis and TCA cycle in ovarian cancer.硫酸乙酰肝素酶-1(HSulf-1)缺乏决定了卵巢癌中糖酵解和三羧酸循环的代谢重编程。
Oncotarget. 2015 Oct 20;6(32):33705-19. doi: 10.18632/oncotarget.5605.
2
Forecasting individual breast cancer risk using plasma metabolomics and biocontours.利用血浆代谢组学和生物轮廓预测个体乳腺癌风险。
Metabolomics. 2015;11(5):1376-1380. doi: 10.1007/s11306-015-0793-8. Epub 2015 Mar 10.
3
Conditional Survival of Esophageal Cancer: An Analysis from the SEER Registry (1988-2011).
靶向肿瘤微环境中代谢途径的纳米药物:未来展望与人工智能的作用
Metabolites. 2025 Mar 13;15(3):201. doi: 10.3390/metabo15030201.
4
Cancer associated fibroblasts and metabolic reprogramming: unraveling the intricate crosstalk in tumor evolution.癌症相关成纤维细胞与代谢重编程:揭开肿瘤演进中复杂的串扰。
J Hematol Oncol. 2024 Sep 2;17(1):80. doi: 10.1186/s13045-024-01600-2.
5
Metabolomic profiling of upper GI malignancies in blood and tissue: a systematic review and meta-analysis.上消化道恶性肿瘤的血液和组织代谢组学分析:系统评价和荟萃分析。
J Cancer Res Clin Oncol. 2024 Jul 1;150(7):331. doi: 10.1007/s00432-024-05857-5.
6
Gut Microbiota, Human Blood Metabolites, and Esophageal Cancer: A Mendelian Randomization Study.肠道微生物群、人体血液代谢物与食管癌:一项孟德尔随机化研究。
Genes (Basel). 2024 Jun 2;15(6):729. doi: 10.3390/genes15060729.
7
Combining fecal microbiome and metabolomics reveals diagnostic biomarkers for esophageal squamous cell carcinoma.联合粪便微生物组和代谢组学揭示食管鳞癌的诊断生物标志物。
Microbiol Spectr. 2024 May 2;12(5):e0401223. doi: 10.1128/spectrum.04012-23. Epub 2024 Mar 18.
8
Purine salvage-associated metabolites as biomarkers for early diagnosis of esophageal squamous cell carcinoma: a diagnostic model-based study.嘌呤补救相关代谢物作为食管鳞状细胞癌早期诊断的生物标志物:一项基于诊断模型的研究
Cell Death Discov. 2024 Mar 14;10(1):139. doi: 10.1038/s41420-024-01896-6.
9
Multi-omics Combined with Machine Learning Facilitating the Diagnosis of Gastric Cancer.多组学与机器学习相结合助力胃癌诊断
Curr Med Chem. 2024;31(40):6692-6712. doi: 10.2174/0109298673284520240112055108.
10
Zinc treatment reverses and anti-Zn-regulated miRs suppress esophageal carcinomas in vivo.锌治疗可逆转,抗锌调节的微小 RNA 可抑制体内食管癌。
Proc Natl Acad Sci U S A. 2023 May 16;120(20):e2220334120. doi: 10.1073/pnas.2220334120. Epub 2023 May 8.
食管癌的条件生存:基于监测、流行病学和最终结果(SEER)数据库(1988 - 2011年)的分析
J Thorac Oncol. 2015 Oct;10(10):1490-7. doi: 10.1097/JTO.0000000000000649.
4
Characterization of metabolic profile of intact non-tumor and tumor breast cells by high-resolution magic angle spinning nuclear magnetic resonance spectroscopy.通过高分辨率魔角旋转核磁共振波谱法对完整的非肿瘤和肿瘤乳腺细胞的代谢谱进行表征。
Anal Biochem. 2015 Nov 1;488:14-8. doi: 10.1016/j.ab.2015.07.015. Epub 2015 Aug 4.
5
Comparative Metabolomic and Lipidomic Analysis of Phenotype Stratified Prostate Cells.表型分层前列腺细胞的比较代谢组学和脂质组学分析
PLoS One. 2015 Aug 5;10(8):e0134206. doi: 10.1371/journal.pone.0134206. eCollection 2015.
6
A 5.5-year surveillance of esophageal and gastric cardia precursors after a population-based screening in China.在中国进行基于人群的筛查后,对食管和贲门前驱病变进行的5.5年监测。
J Gastroenterol Hepatol. 2015 Dec;30(12):1720-5. doi: 10.1111/jgh.13040.
7
Metabolic signatures differentiate ovarian from colon cancer cell lines.代谢特征可区分卵巢癌细胞系和结肠癌细胞系。
J Transl Med. 2015 Jul 14;13:223. doi: 10.1186/s12967-015-0576-z.
8
Biomarker identification and pathway analysis by serum metabolomics of lung cancer.基于血清代谢组学的肺癌生物标志物鉴定与通路分析
Biomed Res Int. 2015;2015:183624. doi: 10.1155/2015/183624. Epub 2015 Apr 16.
9
Report of cancer incidence and mortality in China, 2010.中国癌症发病率和死亡率报告,2010 年。
Ann Transl Med. 2014 Jul;2(7):61. doi: 10.3978/j.issn.2305-5839.2014.04.05.
10
Serum metabolomic signatures of lymph node metastasis of esophageal squamous cell carcinoma.食管鳞状细胞癌淋巴结转移的血清代谢组学特征
J Proteome Res. 2014 Sep 5;13(9):4091-103. doi: 10.1021/pr500483z. Epub 2014 Aug 27.